Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors	Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder	Recruiting	Phase 2	2026-07-08		NCT07688356

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hanmi Pharm	1
Samsung Medical Center	207

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Samsung Medical Center	Seoul	South Korea	375

Clinical trials